Baird rates Exactech as ‘outperform’: 4 insights

Baird, a brokerage firm, upgraded its analysis of Exactech to “outperform,” according to The Market Digest.

Advertisement

Here are four insights:

 

1. Baird previously rated the company as “neutral.”

 

2. On April 15, Exactech’s stock ended at $21.96.

 

3. The company’s 52-week high is $25.74 and the 52-week low is $16.11.

 

4. Exactech has a market capitalization of $308 million.

 

More articles on devices:
Orthofix shares reach new 1-year high: 3 points
1k Hunter Medical’s ElbowLOC Arm Positioning System procedures complete: 3 notes
Dr. Robert Rovner uses Coflex as an alternative treatment for spinal stenosis — 5 highlights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Providence Medical Technology, a spinal technology company, has appointed Lane Major as president and CEO. Mr. Major also joined the…

  • Alphatec Holdings reported total revenue of $214 million for the second quarter ended June 30, up 15% year over year.…

Advertisement

Comments are closed.